Dr. Chaudrey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Lahey Hospital and Medical Center
41 Mall Rd
Burlington, MA 01805Phone+1 718-744-8744
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2015 - 2016
- University of Oklahoma Health Sciences CenterFellowship, Gastroenterology, 2012 - 2015
- SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2003 - 2006
- King Edward Medical UniversityClass of 2000
Certifications & Licensure
- MD State Medical License 2010 - 2026
- MA State Medical License 2019 - 2025
- MN State Medical License 2015 - 2018
- OK State Medical License 2012 - 2016
- NY State Medical License 2006 - 2012
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Poster of distinction DDW, 2015
- Best clinical vignette award ACG Annual Meeting, 2014
- Best Research Scholarly Activity 2009
- Join now to see all
Publications & Presentations
PubMed
- 53 citationsVedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.Neeraj Narula, Farhad Peerani, Joseph Meserve, Gursimran Kochhar, Khadija Chaudrey
The American Journal of Gastroenterology. 2018-09-01 - 234 citationsThe Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY ConsortiumParambir S. Dulai, Siddharth Singh, Xiaoqian Jiang, Farhad Peerani, Neeraj Narula
The American Journal of Gastroenterology. 2016-08-01 - 50 citationsPredictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.Eugenia Shmidt, Gursimran Kochhar, Justin Hartke, Prianka Chilukuri, Joseph Meserve
Inflammatory Bowel Diseases. 2018-10-12
Journal Articles
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumLeah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
- Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumGursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature
- A Simple Clinical Scoring Index to Predict Clinical Remission or Mucosal Healing with Vedolizumab in Moderate-Severe Crohn�s Disease � Results from the VICTORY ConsortiumAmerican Journal of Gastroenterology, 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Predictors of clinical and endoscopic response with vedolizumab for the treatment of moderately-severely active ulcerative colitis: results from the US VICTORY consortiumChaudrey KH, Digital oral presentation, 12th Congress of ECCO - Inflammatory Bowel Diseases, DDW, Barcelona, Spain, 1/1/2017
- Efficacy and Predictors of Outcomes of Vedolizumab for Crohn's Disease in Clinical PracticeChaudrey KH, DDW, 1/1/2016
- Efficacy and Predictors of Outcomes of Vedolizumab for Ulcerative Colitis in Clinical PracticeChaudrey KH, DDW, 1/1/2016
- Join now to see all
Lectures
- Assessing risk factors predicting loss of response to vedolizumab in ulcerative colitis and Crohn�s disease: outcomes from the US VICTORY consortium1/1/2016
- Mucosal healing with vedolizumab in ulcerative colitis and Crohn�s disease: outcomes from the US VICTORY consortium1/1/2016
- Improving Vaccination Rates in IBD Patients-implementation a documentation template1/1/2015
- Join now to see all
Press Mentions
- Suny Downstate Gastroenterology FellowshipDecember 17th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: